Morningstar® Stock Report™

Cronos Group Inc CRON

Último Precio
2.37
Cambio del día
-0.04|-1.66%

a 19/04/2024
19:13:37 EDT | USD  Retraso mínimo: 15 minutos

Bid/OffersRango del DíaVolumen90d Ave VolCapitalización
2.33 - 2.352.34 - 2.453,881,4852,953,899897.00Mill
Último Cierre52 Week RangeP/UDividendo %ISIN
2.411.64 - 2.9965.36-CA22717L1013

Cotización Cronos Inc

Mr. Lee Davidson, Head of Quantitative Research
The conduct of Morningstar's analysts is governed by Morningstar's Code of Ethics, Securities Trading and Disclosure Policy, and Investment Research Integrity Policy. For information regarding conflicts of interest, please click here.
Fair Value is derived from a detailed projection of a company’s future cash flows. Analysts create custom industry and company assumptions to feed income statement, balance sheet, and capital investment assumptions into a proprietary discounted cash flow modeling template. Scenario analysis, in-depth competitive advantage analysis, and a variety of other analytical tools are used to augment the discounted cash flow process. Combining analysts’ financial forecasts with the firm’s economic moat helps us assess how long returns on invested capital are likely to exceed the firm’s cost of capital. Because we are modeling free cash flow to the firm—representing cash available to provide a return to all capital providers—we discount future cash flows using the weighted average of the costs of equity, debt, and preferred stock (and any other funding sources), using expected future proportionate long-term, market-value weights. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Qualitative Fair Value, please click here.
Cuentas Financieras
202120222023
Más...
Cuenta de Resultados
Ingresos74.4491.9087.24
Resultado Operativo-196.92-116.01-79.91
Resultado Neto-396.11-168.73-73.96
Beneficio Básico por Acción-1.07-0.45-0.19
Num Medio Acciones diluidas en circulación370377381
Balance
Activo Corriente1,079.72960.16933.31
Activos no corrientes318.02252.85206.78
Total Activo 1,397.741,213.011,140.09
Pasivo corriente54.3768.1241.40
Total Pasivo---
Capital Total1,337.241,143.891,099.57
Flujo de Caja
Flujo de caja operativo-153.62-88.95-42.84
Inversiones de Capital-12.26-5.03-3.42
Flujo de Caja Libre-165.88-93.98-46.26

En millones, excepto "EPS básico". La moneda es USD.

Perfil de la compañía

Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.

Sector

Atención sanitaria

Industria

Fabricante de Medicamentos - Especializado y Genérico

Estilo de acciones

Peq-Mixto

Fin Ejercicio Fiscal

diciembre

Empleados

356
Principales Características
Más...
Precio/Beneficio 12 m-12.68
Precio/Valor contable0.84
Precio/Ventas TTM10.52
Crec Ingresos (media 3 a)23.14
Crec BPA (media 3 a)-
Margen operativo-91.60
Margen neto-84.78
ROE 12 m-6.59
Deuda/Fondos propios0.00
Dividendos
AntÚltimo
Fecha declaradat.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Pagadot.b.c.t.b.c.
Cantidad0.000.00
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures